Fredun Pharmaceuticals Limited has formally notified the stock exchanges about its upcoming board meeting scheduled for February 9, 2026. The pharmaceutical company will present its third quarter financial performance for the period ended December 31, 2025, marking a significant milestone in its fiscal year reporting cycle.

Board Meeting Details

The company has issued prior intimation under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming the board meeting agenda and timeline.

Trading Window Restrictions

In accordance with Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Fredun Pharmaceuticals has implemented mandatory trading restrictions. The trading window for dealing in the company's securities will remain closed for all restricted personnel until 48 hours after the financial results declaration.

The trading window closure affects:

• Company Directors
• Officers and Key Managerial Personnel
• Designated Employees

Regulatory Compliance and Disclosure

The intimation has been filed with BSE Limited and is available on multiple platforms for stakeholder access. The company maintains transparency through proper disclosure channels, with the notification accessible on both the company's official website at www.fredungroup.com and BSE Limited's website at www.bseindia.com .

The formal communication was signed by Fredun Nariman Medhora, Managing Director (DIN: 01745348), ensuring proper authorization and compliance with corporate governance requirements. This scheduled board meeting represents the company's commitment to timely financial reporting and regulatory adherence in the pharmaceutical sector.

Fredun Pharmaceuticals has announced an Extra-Ordinary General Meeting (EGM) scheduled for February 16, 2026 at 09:00 AM through video conferencing. The pharmaceutical company will seek shareholder approval for the appointment of Ms. Pooja Narendra Sanghavi as Non-Executive Independent Director.

Meeting Details and Agenda

The EGM will be conducted through Video Conferencing (VC) and Other Audio Visual Means (OAVM) in compliance with regulatory circulars. The primary agenda involves passing a special resolution for Ms. Sanghavi's appointment as Non-Executive Independent Director for a five-year term.

Director Profile and Qualifications

Ms. Pooja Narendra Sanghavi (DIN: 11387388) was initially appointed as Additional Director by the Board on November 28, 2025. She brings significant expertise in corporate governance and regulatory compliance to the company.

Her core competencies include convening Board and Committee meetings, handling annual filings with ROC, BSE, and SEBI, managing corporate actions like preferential allotments and buy-backs, and compliance with listing agreements. She has also demonstrated expertise in Secretarial Audit and complex corporate matters involving NCLT and RBI filings.

E-Voting Procedures and Timeline

The company has established comprehensive e-voting procedures through National Securities Depository Limited (NSDL) to facilitate shareholder participation. Ms. Kala Agarwal, Practicing Company Secretary, has been appointed as Scrutinizer for the voting process.

Shareholders holding securities in demat mode with NSDL or CDSL can access e-voting through their respective depository login credentials. The company has provided detailed login procedures for different categories of shareholders, including individual and institutional investors.

Regulatory Compliance and Documentation

The appointment requires special resolution approval under Sections 149, 150, and 152 of the Companies Act, 2013, along with Schedule IV provisions. The company has received all necessary declarations from Ms. Sanghavi, including:

• Consent to act as Director in Form DIR-2
• Declaration of independence under Section 149(6)
• Confirmation of non-disqualification under Section 164
• Compliance with SEBI regulations and listing requirements

The Board of Directors, based on the Nomination and Remuneration Committee's recommendation, believes Ms. Sanghavi possesses the required skills and expertise for effective functioning as Non-Executive Independent Director. Her appointment aligns with the company's governance framework and regulatory compliance requirements.

Shareholder Participation Guidelines

Shareholders can participate in the EGM through the NSDL e-voting platform, with facility available for 1000 members on first-come-first-served basis. Large shareholders holding 2% or more, promoters, institutional investors, and key personnel can attend without restrictions. The company encourages laptop usage for better meeting experience and stable internet connectivity to avoid technical disruptions.